TScan Therapeutics
TCRX
#8415
Rank
โ‚น13.46 B
Marketcap
โ‚น252.35
Share price
1.37%
Change (1 day)
-47.23%
Change (1 year)

TScan Therapeutics (TCRX) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น23.03 Billion

According to TScan Therapeutics's latest financial reports the company has โ‚น23.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

TScan Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น15.98 B60.97%
2022-12-31โ‚น9.93 B-17.32%
2021-12-31โ‚น12.01 B372.16%
2020-12-31โ‚น2.54 B-14.57%
2019-12-31โ‚น2.97 B